The image shows the Biovectra logo with the tagline "A part of Agilent," featuring geometric shapes in blue, yellow, and text in purple and black.
The image is blank with no visible content, people, or landmarks. It's entirely white and featureless.

We Are Attending BIO International 2025

Meet with BIOVECTRA in Boston
June 16 - 19, 2025

BIOVECTRA is a North American CDMO specializing in the clinical-to-commercial scale production of high-quality regulated APIs and intermediates, including:

  • Fermentation & Biologics
  • Small Molecule Synthesis
  • Peptide & Small Molecule Purification
  • pDNA, mRNA & LNP 
  • Highly Potent APIs
  • Bioreagents
  • Fill/Finish

Our team – backed by 50+ years of experience – looks forward to the opportunity to put our flexible, innovative manufacturing solutions at your disposal.

Meet With Us

Schedule a meeting with us and discover how we can support your projects and solve your most complex challenges.

SEO plus – Test

  • 20+ years at GSK, leading R&D activities on multiple vaccine programs
  • Recently held positions in industry include: Senior Director (Function Head), Protein Biochemistry; Director, Antigen Design & Prototype Production; and, Associate Director, Antigen Design and Protein Characterization.
  • Key areas of expertise are:
    • Process development of protein Biologics/Recombinant Antigens
    • Recombinant protein expression (mammalian, insect, yeast, bacterial)
    • Production/design of Viral Vectors, mRNA vaccines, Bacterial outer membrane vesicles
    • Protein Engineering and Structural Biology
    • Defining quality attributes, biophysical characterization of proteins, and analytical strategy
  • Post graduate degrees in Functional Genomics (Université Laval) and Bioinformatics (MIT); M. Sc. Microbiology and Immunology (Laval).
  • 25+ Patent & 5 Scientific Publications